V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002316 | 250004491 | 1.71 | 99.3 | Palliative (P) | 2018-07-01 | 2018-11-29 | Atezolizumab | 02 | N | CARBOPLATIN + PEMETREXED | 101781046 |
| 250002317 | 250004492 | null | null | Palliative (P) | 2019-12-02 | 2019-12-02 | WT SIOP 2002 01 post op Vinc alone | null | null | CARBOPLATIN | 100532326 |
| 250002319 | 250004493 | 1.69 | null | null | 2018-12-01 | 2018-12-15 | CISPLATIN + FLUOROURACIL | 02 | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101205298 |
| 250002323 | 250004497 | null | null | Palliative (P) | 2020-06-20 | 2020-07-11 | IVADo | 02 | null | ENZALUTAMIDE | 101344433 |
| 250002324 | 250004498 | null | 50 | null | 2019-02-08 | 2019-02-08 | null | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101411743 |
| 250002326 | 250004499 | null | null | Palliative (P) | null | 2018-04-12 | null | null | N | NB HRNBL-1 COJEC IND COURSE C | 100452835 |
| 250002331 | 250004504 | 1.73 | 108 | null | 2019-01-08 | 2019-01-09 | Pazopanib | 02 | null | GEMCITABINE | 100688317 |
| 250002332 | 250004505 | 1.66 | 16.9 | null | 2017-09-06 | 2017-09-24 | CARBOPLATIN | Y | null | CAPECITABINE + OXALIPLATIN | 101666138 |
| 250002335 | 250004508 | 1.8 | 55.01 | null | 2020-02-17 | 2020-03-01 | null | 02 | null | CAPECITABINE + OXALIPLATIN | 100304734 |
| 250002339 | 250004510 | null | null | Palliative (P) | null | 2016-03-16 | CYCLOPHOSPHAMIDE + DOXORUBICIN | null | N | CARBOPLATIN + FLUOROURACIL | 101799261 |
| 250002341 | 250004511 | null | null | Curative (C) | null | 2018-01-07 | Fluorouracil+Mitomycin+RT (Bladder) | null | null | TRIAL UNSPECIFIED | 101434452 |
| 250002343 | 250004513 | 1.72 | 73.9 | Palliative (P) | 2022-03-17 | 2022-04-01 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN | 100691337 |
| 250002346 | 250004516 | 1.69 | 88 | Palliative (P) | null | 2017-10-29 | null | null | null | FLUOROURACIL + OXALIPLATIN | 100692623 |
| 250002350 | 250004519 | null | null | Palliative (P) | 2019-08-31 | 2019-08-31 | Trial Unspecified | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101415326 |
| 250002352 | 250004520 | null | null | Curative (C) | 2018-05-27 | 2018-06-05 | IPILIMUMAB + NIVOLUMAB | 02 | N | DOXORUBICIN | 100092336 |
| 250002353 | 250004521 | 1.56 | 68.4 | null | 2019-06-07 | 2019-06-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | IRINOTECAN + MDG | 101313167 |
| 250002360 | 250004526 | null | null | null | 2018-02-04 | 2018-02-04 | Tivozanib | 02 | null | TRIAL UNSPECIFIED | 101227963 |
| 250002363 | 250004528 | 1.58 | 47 | null | 2019-03-09 | 2019-03-12 | NB HRNBL-1 BUMEL MAT | Y | N | DOXORUBICIN + OLARATUMAB | 100936005 |
| 250002371 | 250004531 | 1.94 | 67.3 | Palliative (P) | null | 2020-04-30 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | GEMCARBO | 100763637 |
| 250002372 | 250004532 | 1.53 | 73 | Palliative (P) | 2018-10-01 | 2018-10-22 | IPILIMUMAB + NIVOLUMAB | null | null | CARBOPLATIN + PACLITAXEL | 100310475 |
| 250002375 | 250004535 | null | null | null | null | 2017-12-10 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100898708 |
| 250002380 | 250004539 | null | null | 03 | null | 2019-12-12 | DOXORUBICIN | null | N | ECX | 101060284 |
| 250002383 | 250004541 | null | null | Palliative (P) | 2018-01-11 | 2018-01-22 | null | 01 | null | CAPECITABINE + IRINOTECAN | 101814106 |
| 250002384 | 250004542 | 1.66 | 61.4 | null | 2016-09-25 | 2016-10-09 | CARBOPLATIN + FLUOROURACIL | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101724276 |
| 250002391 | 250004545 | 1.76 | 101.8 | null | 2018-09-20 | 2019-01-19 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101434151 |
| 250002392 | 250004546 | 1.74 | 83.2 | null | 2017-03-12 | 2017-04-04 | BCG Intravesical | 02 | null | PAZOPANIB | 100160132 |
| 250002396 | 250004548 | 1.56 | 102.2 | null | 2019-06-14 | 2019-06-15 | null | null | null | ENZALUTAMIDE | 100619159 |
| 250002397 | 250004549 | null | null | null | null | 2017-04-11 | Carboplatin + Pemetrexed | null | null | DOXORUBICIN + OLARATUMAB | 101234581 |
| 250002411 | 250004561 | 1.75 | 79 | null | 2019-12-29 | 2019-12-31 | TIP | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100395127 |
| 250002421 | 250004570 | 1.67 | 76 | null | 2019-06-11 | 2019-08-19 | null | 02 | null | PACLITAXEL | 101452322 |
| 250002426 | 250004572 | 0 | 63.4 | Palliative (P) | 2019-01-16 | 2019-01-24 | IMATINIB | 02 | N | MITOMYCIN INTRAVESICULAR | 101056654 |
| 250002433 | 250004578 | 1.69 | null | null | 2018-03-29 | 2018-04-02 | REGORAFENIB | 02 | null | PANITUMUMAB | 101423039 |
| 250002440 | 250004584 | 1.64 | 68 | Palliative (P) | 2018-04-12 | 2018-04-12 | null | 02 | N | DABRAFENIB + TRAMETINIB | 101694139 |
| 250002446 | 250004589 | 1.63 | 67.85 | null | null | 2017-06-16 | CETUXIMAB | null | null | CAPECITABINE + OXALIPLATIN | 100066926 |
| 250002449 | 250004591 | 1.79 | 65 | Adjuvant (A) | null | 2018-06-24 | REGORAFENIB | N | N | IMATINIB | 101106064 |
| 250002450 | 250004592 | 1.78 | 12.3 | Curative (C) | 2016-01-30 | 2016-01-31 | Dinutuximab Beta | 02 | N | GEMCITABINE | 101060021 |
| 250002452 | 250004593 | 1.73 | 88 | null | null | 2019-09-11 | Carboplatin AUC 2 - 5 | null | N | TRIAL UNSPECIFIED | 100977041 |
| 250002453 | 250004594 | null | null | Curative (C) | 2019-11-18 | 2020-01-15 | Paclitaxel 7 day | 02 | N | CAPECITABINE + OXALIPLATIN | 101061103 |
| 250002458 | 250004598 | null | null | null | 2018-03-17 | 2018-03-18 | Capecitabine + Oxaliplatin 21day | 02 | null | IPILIMUMAB + NIVOLUMAB | 101753644 |
| 250002464 | 250004601 | null | null | null | null | 2019-03-05 | VIDE | null | N | FLUOROURACIL + MITOMYCIN | 100226924 |
| 250002468 | 250004605 | null | null | Palliative (P) | 2019-01-19 | 2019-09-13 | null | 02 | null | DOCETAXEL | 100463497 |
| 250002469 | 250004606 | 1.76 | 91.8 | null | 2018-05-16 | 2020-02-27 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + FLUOROURACIL | 100269129 |
| 250002471 | 250004608 | 1.62 | 64.9 | Palliative (P) | 2019-02-05 | 2019-03-06 | Trial Unspecified | 02 | Y | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 101703030 |
| 250002472 | 250004609 | 1.69 | 24.6 | null | null | 2017-11-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100498184 |
| 250002473 | 250004610 | 1.64 | 80.6 | Palliative (P) | 2020-12-16 | 2021-01-17 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 101623147 |
| 250002476 | 250004613 | 1.59 | 84.8 | Palliative (P) | 2018-05-09 | 2018-05-15 | null | 02 | N | EC | 100545806 |
| 250002482 | 250004616 | 1.72 | 61 | Neo-adjuvant (N) | null | 2018-07-21 | null | 02 | N | TIVOZANIB | 101244074 |
| 250002483 | 250004617 | 1.88 | 85.85 | Palliative (P) | 2016-09-28 | 2017-07-01 | null | 02 | null | VANDETANIB | 100349658 |
| 250002485 | 250004618 | 1.73 | 88.3 | Palliative (P) | 2019-10-23 | 2019-10-23 | Tivozanib | N | N | CARBOPLATIN + PEMETREXED | 100885630 |
| 250002489 | 250004622 | null | null | null | null | 2018-09-27 | STS Rhabdo RMS 2005 Vin Cyclo | null | N | DOXORUBICIN + OLARATUMAB | 100039987 |